Biotech

All Articles

Lilly posts more good records on its own once a week the hormone insulin prospect

.On the heels of an FDA rejection for its chief rivalrous Novo Nordisk, Eli Lilly is gaining ground ...

IN 8bio standstills phase 2 trial, lays off one-half of workforce

.Merely a few months after application the very first patient in a period 2 test for newly detected ...

Lilly, Haya ink $1B biobuck weight problems contract to browse black genome

.Eli Lilly's hunt for obesity intendeds has led it to the darker genome. The Big Pharma has crafted ...

ArsenalBio elevates $325M, pivots far from past lead asset

.Toolbox Biosciences is moving on up. The tissue treatment company has actually added $325 million i...

Lilly- supported fat loss biotech files IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to de...

Aelis' cannabis use drug fails phase 2b, steering Indivior to reconsider $100M possibility

.Aelis Farma's hopes of securing an easy, good choice on a $one hundred thousand choice remittance h...

ProKidney standstills stage 3 test not needed for cell therapy permission

.ProKidney has quit among a pair of stage 3 trials for its own tissue therapy for kidney health cond...

Vaxcyte climbs on 'magnificent' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what professionals referred to as "sensational" phase 1/2 data for its own 31-vale...

Recursion's brain health condition trial shows insufficient documentation of efficacy

.Recursion has discovered via a very early examination of its tech-enabled method to medicine revela...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Contact it a case of great chemical make up: Acepodia, a biotech based on Nobel Prize-winning scien...